These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31478230)

  • 1. Device exchange from Heartmate II to HeartWare HVAD.
    Beaupre RA; Alnajar A; Sugiura T; Chou B; Lamba HK; Kurihara C; Kawabori M; Critsinelis AC; Santiago A; Morgan JA
    J Card Surg; 2019 Nov; 34(11):1204-1207. PubMed ID: 31478230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First series of left ventricular assist device exchanges to HeartMate 3.
    Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
    Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.
    Lalonde SD; Alba AC; Rigobon A; Ross HJ; Delgado DH; Billia F; McDonald M; Cusimano RJ; Yau TM; Rao V
    J Card Surg; 2013 Sep; 28(5):604-10. PubMed ID: 23844652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II.
    Magruder JT; Grimm JC; Crawford TC; Tedford RJ; Russell SD; Sciortino CM; Whitman GJR; Shah AS
    Ann Thorac Surg; 2017 May; 103(5):1505-1511. PubMed ID: 27765177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.
    Abicht T; Gordon R; Meehan K; Stosor V; McCarthy P; McGee E
    ASAIO J; 2013; 59(2):188-92. PubMed ID: 23438785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience.
    Agarwal R; Kyvernitakis A; Soleimani B; Milano CA; Davis RP; Kennedy JL; Yarboro L; Benza RL; Moraca RJ; Bailey SH
    Ann Thorac Surg; 2019 Oct; 108(4):1178-1182. PubMed ID: 31059685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices.
    Anjum A; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Civitello AB; Etheridge WB; Delgado RM; Simpson L; George JK; Nair AP; Frazier OH; Morgan JA
    J Artif Organs; 2018 Sep; 21(3):285-292. PubMed ID: 29766321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome and Comparison of Three Different Left Ventricular Assist Devices in a High-Risk Cohort.
    Zhigalov K; Mashhour A; Szczechowicz M; Mkalaluh S; Karagezian S; Gogia I; Isaev M; Kadyraliev BK; Easo J; Ennker J; Eichstaedt HC; Weymann A
    Artif Organs; 2018 Nov; 42(11):1035-1042. PubMed ID: 29774558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
    Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
    J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.